Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Investment Income: 2022-2024

Historic Non Operating Investment Income for Biofrontera (BFRI) over the last 3 years, with Dec 2024 value amounting to -$14,000.

  • Biofrontera's Non Operating Investment Income rose 150.00% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17,000, marking a year-over-year increase of 97.87%. This contributed to the annual value of -$14,000 for FY2024, which is 99.81% up from last year.
  • Latest data reveals that Biofrontera reported Non Operating Investment Income of -$14,000 as of FY2024, which was up 99.81% from -$7.4 million recorded in FY2023.
  • Biofrontera's 5-year Non Operating Investment Income high stood at $1.7 million for FY2022, and its period low was -$7.4 million during FY2023.
  • Moreover, its 3-year median value for Non Operating Investment Income was -$14,000 (2024), whereas its average is -$1.9 million.
  • In the last 5 years, Biofrontera's Non Operating Investment Income tumbled by 524.79% in 2023 and then skyrocketed by 99.81% in 2024.
  • Over the past 3 years, Biofrontera's Non Operating Investment Income (Yearly) stood at $1.7 million in 2022, then slumped by 524.79% to -$7.4 million in 2023, then soared by 99.81% to -$14,000 in 2024.